Unichem Laboratories (NSE:UNICHEMLAB) ROCE %: 3.95% (As of Mar. 2026)


NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
65 GF Score
Price ₹433.00
GF Value ₹686.53
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Unichem Laboratories ROCE %?

Unichem Laboratories NSE:UNICHEMLAB -0.13% 65 ROCE % is 3.95% as of Mar. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 65/100 and a GF Value™ of ₹686.53 (Significantly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Unichem Laboratories's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.95%.

Unichem Laboratories  (NSE:UNICHEMLAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Unichem Laboratories ROCE % Related Terms

Unichem Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories ROCE % Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 -6.02 -2.47 6.87 11.93

Unichem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.82 -0.38 -0.41 47.39 3.95
NSE:UNICHEMLAB
65GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories ROCE % Calculation

Unichem Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=3239.7/( ( (35694 - 9919.7) + (37374.4 - 8859.4) )/ 2 )
=3239.7/( (25774.3+28515)/ 2 )
=3239.7/27144.65
=11.93 %

Unichem Laboratories's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1127.2/( ( (0 - 0) + (37374.4 - 8859.4) )/ 1 )
=1127.2/( ( 0 + 28515 )/ 1 )
=1127.2/28515
=3.95 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.95% mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a ROCE % of 3.95% as of Mar. 2026.
Is Unichem Laboratories' ROCE % too high?
Unichem Laboratories' current ROCE % is 3.95%. The Drug Manufacturers industry median ROCE % is 7.00. Unichem Laboratories' value of 3.95% is 43.5% below this industry median. Overall, Unichem Laboratories has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' ROCE % compare to ZTS?
Unichem Laboratories' ROCE % of 3.95% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Unichem Laboratories' value of 3.95% is 43.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unichem Laboratories's current ROCE % of 3.95% is 43.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unichem Laboratories's current ROCE % is 3.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹686.53, compared to a current price of ₹433.00 — trading 36.9% below its estimated fair value. The current ROCE % is 3.95% and 43.5% below the Drug Manufacturers industry median of 7.00. Unichem Laboratories' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current ROCE % is 3.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹433.00 is trading 36.9% below its estimated GF Value™ of ₹686.53. GuruFocus considers Unichem Laboratories to be Significantly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • ROCE %: 3.95%
  • GF Value™: ₹686.53 vs. price of ₹433.00 (36.9% below fair value)
  • GF Score™: 65/100 with 3 warning signs
  • Industry Position: 43.5% below the Drug Manufacturers median

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
65GF Score

Get the complete analysis for NSE:UNICHEMLAB

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹433.00
Price
₹686.53
GF Value